 KANSAS CITY, Kan., Oct. 20, 2022 GLOBE NEWSWIRE -- Cingulate Inc. NASDAQ: CING, a biopharmaceutical company utilizing its proprietary Precision Timed ReleaseTM PTRTM drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Cingulate Chairman CEO Shane J. Schaffer will present at the LD Micro Main Event XV investor conference on October 26, 2022. 